Screener / SEC EDGAR /CIK 0001516513 /10-K filed May 19, 2026, compared with May 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · IT Services

Doximity, Inc. DOCS

Compare with peers Embed
Planned sales, announced before they happen

6 trading plans running, 22 Form 144 notices for $3.7M

10-Q, 10-K and Form 144
Plans running now 6 Matthew Sonefeldt, John Vaughan, Kira Wampler, Siddharth Sitaram, Tim Cabral, Ms. Phoebe Yang
Plans adopted 17 reported since May 26, 2023 Form 144 notices 22 $3.7M the sellers expected to sell

What DOCS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 12, 2024 to May 26, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Matthew Sonefeldt
Chief Financial Officer
Adopted 10b5-1 plan Aug 31, 2026 10-Q Nov 5, 2026
What the company wrote
On August 31, 2026, Mr. Matthew Sonefeldt, Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on August 31, 2027, providing for the sale of up to 17,644 shares of the Company’s Class A common stock and other net vested shares of Class A common stock pursuant to a series of market orders.
John Vaughan
General Counsel of the Company
Adopted 10b5-1 plan Aug 11, 2026 10-Q Nov 5, 2026
What the company wrote
On August 11, 2026, Mr. John Vaughan, General Counsel of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on June 1, 2027, providing for the sale of a portion of the shares of the Company’s Class A common stock acquired through the Company’s employee stock purchase plan.
Kira Wampler
director of the Company
Adopted 10b5-1 plan May 26, 2026 10-Q Aug 6, 2026
What the company wrote
On May 26, 2026, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on May 26, 2028, providing for the sale of up to 54,000 shares of stock issuable upon the exercise of vested stock options.
Phoebe Yang
director of the Company
Adopted 10b5-1 plan May 22, 2026 10-Q Aug 6, 2026
What the company wrote
On May 22, 2026, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on October 14, 2026, providing for the sale of up to 1,290 shares of common stock.
Anna Bryson
Chief Financial Officer
Ended 10b5-1 plan Apr 27, 2026 10-Q Aug 6, 2026
What the company wrote
On April 27, 2026, Ms. Anna Bryson, former Chief Financial Officer of the Company, terminated a Rule 10b5-1 trading plan that she had previously entered into on May 27, 2025. The plan, which was scheduled to expire pursuant to its terms on May 27, 2026, provided for the sale of up to 160,000 shares of the Company’s Class A common stock issuable upon the exercise of vested stock options. A total of 40,000 shares were sold under the plan prior to its termination.
Siddharth Sitaram
Chief Accounting Officer
Adopted 10b5-1 plan Feb 27, 2026 10-K May 19, 2026
What the company wrote
On February 27, 2026, Mr. Siddharth Sitaram, Chief Accounting Officer, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Sitaram’s Rule 10b5-1 Trading Plan, which has a term from February 27, 2026 to December 31, 2026, provides for the potential exercise of 38,800 vested stock options and the associated sale of sufficient shares of the Company’s Class A common stock to cover exercise costs and estimated tax withholding amounts plus customary brokerage fess pursuant to a series of market orders.
Tim Cabral
director of the Company
Adopted 10b5-1 plan Feb 19, 2026 10-K May 19, 2026
What the company wrote
On February 19, 2026, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 19, 2026 to May 21, 2027, provides for the potential exercise of vested stock options and the associated sale of up to 60,000 shares of the Company’s Class A common stock in the aggregate and other net vested shares of Class A common stock pursuant to a series of market orders. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, he held no net vested shares. Mr. Cabral’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of his Rule 10b5-1 Trading Plan.
Ms. Phoebe Yang
director
Adopted 10b5-1 plan Nov 26, 2025 10-Q Feb 5, 2026
What the company wrote
On November 26, 2025, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from November 26, 2025 to November 26, 2027, provides for the sale of 3,000 shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 14,729 shares of common stock. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of Ms. Yang’s Rule 10b5-1 Trading Plan.
Anna Bryson
Chief Financial Officer
Ended 10b5-1 plan May 22, 2025 10-Q Aug 7, 2025
What the company wrote
On May 27, 2025, Ms. Bryson, adopted a new Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s new Rule 10b5-1 Trading Plan, which has a term from May 27, 2025 to May 27, 2026, provides for the exercise and sale of 160,000 shares of common stock pursuant to a series of market orders.
Regina Benjamin
director
Adopted 10b5-1 plan Feb 26, 2025 10-K May 20, 2025
What the company wrote
On February 26, 2025, Dr. Regina Benjamin, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of the Company’s Class A common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c). Dr. Benjamin’s Rule 10b5-1 Trading Plan, which has a term from February 26, 2025 to May 28, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 65,000 shares of the Company’s Class A common stock in the aggregate pursuant to a series of market orders.
Tim Cabral
director
Adopted 10b5-1 plan Feb 13, 2025 10-K May 20, 2025
What the company wrote
On February 13, 2025, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 13, 2025 to May 15, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 120,000 shares of the Company’s Class A common stock in the aggregate and other net vested shares of Class A common stock pursuant to a series of market orders. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, he held no net vested shares. Mr. Cabral’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of his Rule 10b5-1 Trading Plan.
Phoebe Yang
director
Ended 10b5-1 plan Feb 12, 2025 10-K May 20, 2025
What the company wrote
On February 12, 2025, Ms. Phoebe Yang, a director of the Company, terminated a Rule 10b5-1 Trading Plan that she had previously entered into on November 12, 2024. Ms. Yang’s Rule 10b5-1 Trading Plan, which was scheduled to expire pursuant to its terms on September 19, 2025, provided for the sale of 33.33% of net vested shares of Class A common stock pursuant to a series of market orders.
Anna Bryson
Chief Financial Officer
Adopted 10b5-1 plan Nov 12, 2024 10-Q Feb 6, 2025
What the company wrote
On November 12, 2024, Ms. Anna Bryson, the Chief Financial Officer of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to May 29, 2026, provides for the exercise and sale of 375,000 shares of common stock pursuant to a series of market orders.
Kira Wampler
director
Adopted 10b5-1 plan Nov 12, 2024 10-Q Feb 6, 2025
What the company wrote
On November 12, 2024, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Wampler’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to November 12, 2026 , provides for the exercise and sale of 54,000 shares of common stock pursuant to a series of market orders.
Phoebe Yang
director
Adopted 10b5-1 plan Nov 12, 2024 10-Q Feb 6, 2025
What the company wrote
On November 12, 2024, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from November 12, 2024 to September 19, 2025, provides for the sale of 33.33% of net vested shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 8,370 net vested shares. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of Ms. Yang’s Rule 10b5-1 Trading Plan.
Tim Cabral
director
Adopted 10b5-1 plan Feb 15, 2024 10-K May 23, 2024
What the company wrote
On February 15, 2024, Mr. Tim Cabral, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 15, 2024 to February 28, 2025, provides for the exercise and sale of 80,000 shares of common stock pursuant to a series of market orders. The plan also provides for the sale of an indeterminate number of net vested shares of common stock pursuant to a market order. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading Plan, Mr. Cabral did not hold any net vested shares. Mr. Cabral’s net vested share amount is currently indeterminable because it will change as additional equity awards vest or shares are subsequently purchased or sold.
Ms. Anna Bryson
Chief Financial Officer
Adopted 10b5-1 plan Nov 30, 2023 10-Q Feb 8, 2024
What the company wrote
On November 30, 2023, Ms. Anna Bryson, the Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Bryson’s Rule 10b5-1 Trading Plan, which has a term from November 30, 2023 to November 29, 2024, provides for the exercise and sale of 120,000 shares of common stock pursuant to a series of market orders.
Ms. Phoebe Yang
director of the Company
Adopted 10b5-1 plan Aug 30, 2023 10-Q Nov 9, 2023
What the company wrote
On August 30, 2023, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from August 30, 2023 to August 14, 2024, provides for the sale of 35% of net vested shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 2,889 net vested shares. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold.
Ms. Kira Wampler
director of the Company
Adopted 10b5-1 plan Aug 24, 2023 10-Q Nov 9, 2023
What the company wrote
On August 24, 2023, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Wampler’s Rule 10b5-1 Trading Plan, which has a term from August 24, 2023 to November 29, 2024, provides for the exercise and sale of 37,500 shares of common stock pursuant to a series of market orders.
Mr. Craig Overpeck
Senior Vice President of Commercial Operations
Adopted 10b5-1 plan May 26, 2023 10-Q Aug 8, 2023
What the company wrote
On May 26, 2023, Mr. Craig Overpeck, the Senior Vice President of Commercial Operations of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Overpeck’s Rule 10b5-1 Trading Plan, which has a term from May 26, 2023 to November 29, 2024, provides for the sale of 9,500 shares of common stock pursuant to a series of market orders.
Show the other 12 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 26, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 5, 2026 TIMOTHY STEPHEN CABRAL
Director
10,721 $375K
Nov 2, 2026 KIRA WAMPLER
Director
2,000 $66K
Oct 14, 2026 SIDDHARTH SITARAM
Officer
2,613 $80K
Oct 1, 2026 KIRA WAMPLER
Director
2,000 $58K
Sep 30, 2026 PHOEBE L YANG WATKIN
Director
1,290 $34K
Sep 15, 2026 SIDDHARTH SITARAM
Officer
2,077 $54K
Sep 1, 2026 KIRA WAMPLER
Director
2,000 $53K
Aug 25, 2026 KIRA WAMPLER
Director
2,000 $50K
Aug 13, 2026 SIDDHARTH SITARAM
Officer
1,770 $44K
Aug 7, 2026 TIMOTHY STEPHEN CABRAL
Director
7,500 $293K
Jul 15, 2026 SIDDHARTH SITARAM
Officer
1,732 $38K
Jun 9, 2026 ANNA COLLINS BRYSON
Officer
63,834 $1.3M
Jun 8, 2026 SIDDHARTH SITARAM
Officer
2,444 $50K
May 11, 2026 SIDDHARTH SITARAM
Officer
2,309 $60K
May 7, 2026 KIRA WAMPLER
Director
9,000 $235K
Apr 10, 2026 SIDDHARTH SITARAM
Officer
2,427 $51K
Mar 10, 2026 SIDDHARTH SITARAM
Officer
2,319 $59K
Mar 3, 2026 KIRA WAMPLER
Director
2,000 $52K
Feb 2, 2026 KIRA WAMPLER
Director
2,000 $75K
Jan 2, 2026 KIRA WAMPLER
Director
2,000 $89K
Dec 1, 2025 KIRA WAMPLER
Director
2,000 $101K
Nov 21, 2025 TIMOTHY CABRAL
Director
10,000 $500K
Show the other 14 notices

From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DOCS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.